Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iSERA LifesciencesBOM:534920 20 Market Cap is ₹1,210.05 Mil as of Aug. 11, 2026. GuruFocus rates BOM:534920 with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 2,934 Software companies, iSERA Lifesciences ranks worse than 79% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). iSERA Lifesciences's share price for the quarter that ended in Mar. 2026 was ₹55.16. iSERA Lifesciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 8.41 Mil. Therefore, iSERA Lifesciences's market cap for the quarter that ended in Mar. 2026 was ₹463.84 Mil.
iSERA Lifesciences's quarterly market cap
increased
from Sep. 2025 (₹2.09 Mil) to Dec. 2025 (₹140.01 Mil) and
increased
from Dec. 2025 (₹140.01 Mil) to Mar. 2026 (₹463.84 Mil).
iSERA Lifesciences's annual market cap
stayed the same
from Mar. 2024 (₹218.56 Mil) to Mar. 2025 (₹218.56 Mil) but then
increased
from Mar. 2025 (₹218.56 Mil) to Mar. 2026 (₹463.84 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. iSERA Lifesciences's Enterprise Value for Today is ₹1,198.02 Mil.
iSERA Lifesciences (BOM:534920) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
iSERA Lifesciences Market Cap Related Terms
iSERA Lifesciences Market Cap Historical Data
* Premium members only.
The historical data trend for iSERA Lifesciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:534920 vs IBM, ACN, FISV: Market Cap Comparison
For the Information Technology Services subindustry, iSERA Lifesciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iSERA Lifesciences Market Cap vs Software Industry
For the Software industry and Technology sector, iSERA Lifesciences's Market Cap distribution charts can be found below:
* The bar in red indicates where iSERA Lifesciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
iSERA Lifesciences's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iSERA Lifesciences (BOM:534920) has a Market Cap of ₹1,210.05 Mil as of Aug. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on iSERA Lifesciences and its competitors. According to the industry distribution chart, iSERA Lifesciences ranks #2318 out of 2934 companies in the Software industry, placing it in the top 79%.
Is iSERA Lifesciences' Market Cap too high?
iSERA Lifesciences' current Market Cap is ₹1,210.05 Mil. Based on the distribution chart, iSERA Lifesciences ranks #2318 out of 2934 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, iSERA Lifesciences has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does iSERA Lifesciences' Market Cap compare to IBM and ACN?
According to the Software industry distribution chart, iSERA Lifesciences ranks #2318 out of 2934 companies for Market Cap. This places iSERA Lifesciences in the lower half of its industry. The industry median Market Cap is 68.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Software company?
The median Market Cap among Software companies is 68.14, based on 2,934 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on iSERA Lifesciences and its competitors. For the Software industry, the median Market Cap is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iSERA Lifesciences's current Market Cap is ₹1,210.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iSERA Lifesciences stock overvalued right now?
iSERA Lifesciences (BOM:534920) has a current Market Cap of ₹1,210.05 Mil. The current Market Cap is ₹1,210.05 Mil. iSERA Lifesciences' overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For iSERA Lifesciences (BOM:534920), the current Market Cap is ₹1,210.05 Mil as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
iSERA Lifesciences Ltd, formally known as Covidh Technologies Ltd, is a technology services provider. The company provides IT and IT-enabled services. It derives revenue majorly from the sale of IT and IT-enabled services and Hardware.
20GF Score
Get the complete analysis for BOM:534920
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:534920 has been successfully added to your 
